Premenstrual use of Prozac approved by U.S. officials
Article Abstract:
Prozac has been approved by the US government as the first drug for major mood problems suffered by premenstrual women. The antidepressant drug, produced by Eli Lilly and Co., will be marketed under the Sarafem brand name.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Lilly antidepressant is dealt a setback
Article Abstract:
The US Food and Drug Administration has decided that more clinical studies are needed for Eli Lilly and Co.'s Cymbalta antidepressant drug. The company's short-term prospects were dealt a setback by the decision.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
No encouraging data on new drug by Lilly
Article Abstract:
Eli Lilly and Co. has been unable to provide positive data on its Cymbalta antidepressant drug. The company was hoping to set a timetable for the drug's approval in the U.S.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Japanese auto sales expected to rise. U.S. car sales eased in January. Porsche expects sales to rise
- Abstracts: Barclays settles trading probe by U.S. regulator. Authorities question Barclays official in criminal probe. Standard Chartered says chief executive is stepping down
- Abstracts: Horlicks remains a staple in India thanks to continuing innovation. In pursuit of Indian stocks
- Abstracts: Roche deal fuels change on books. WTO reaches deal on drugs for poor. Invitrogen comes to Dexter's rescue, adding life to its gene-study trade